DnB Asset Management’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
DnB Asset Management's ASND Position: Q2 2026 in Review
DnB Asset Management reduced its Ascendis Pharma A/S (ASND) stake by 12% in Q2 2026, selling an estimated $99K and leaving 3,090 shares worth $824K. The position accounts for ﹤0.01% of the portfolio, ranked #666.
DnB Asset Management first reported a position in ASND in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.27M in Q4 2025. 164 funds tracked by Wall St. Rank hold ASND as of Q2 2026.
- DnB Asset Management held 3,090 shares of Ascendis Pharma A/S worth $824K as of Q2 2026.
- DnB Asset Management sold 424 Ascendis Pharma A/S shares in Q2 2026, an estimated $99K.
- Ascendis Pharma A/S made up ﹤0.01% of DnB Asset Management's portfolio in Q2 2026, its #666 holding.
- DnB Asset Management first reported a position in Ascendis Pharma A/S in Q2 2024 and has held it in 9 quarters since.
- DnB Asset Management's Ascendis Pharma A/S position peaked at $1.27M in Q4 2025.
- 164 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.
Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.